Overview

Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals With Obesity and NAFLD

Status:
Not yet recruiting

Trial end date:
2023-12-15

Target enrollment:

Participant gender:

Summary

This multicenter, double-blinded, randomized controlled trial aims to evaluate the effect of berberine in reducing visceral and liver adipose tissue among individuals with obesity and non-alcoholic fatty liver disease (NAFLD) in China.

Phase:

Phase 4

Details

Lead Sponsor:

China National Center for Cardiovascular Diseases